OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
A review of 2022 Chinese clinical guidelines on the management of hepatocellular carcinoma: updates and insights
Diyang Xie, Kai Zhu, Zhenggang Ren, et al.
HepatoBiliary Surgery and Nutrition (2023) Vol. 12, Iss. 2, pp. 216-228
Open Access | Times Cited: 90
Diyang Xie, Kai Zhu, Zhenggang Ren, et al.
HepatoBiliary Surgery and Nutrition (2023) Vol. 12, Iss. 2, pp. 216-228
Open Access | Times Cited: 90
Showing 1-25 of 90 citing articles:
Immunosuppressive tumor microenvironment and immunotherapy of hepatocellular carcinoma: current status and prospectives
Ke-Yu Shen, Ying Zhu, Sun‐Zhe Xie, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 41
Ke-Yu Shen, Ying Zhu, Sun‐Zhe Xie, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 41
Histone lactylation promotes multidrug resistance in hepatocellular carcinoma by forming a positive feedback loop with PTEN
Yuan Zeng, Haoran Jiang, Zhoufeng Chen, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 3
Yuan Zeng, Haoran Jiang, Zhoufeng Chen, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 3
Conversion therapy for advanced hepatocellular carcinoma in the era of precision medicine: Current status, challenges and opportunities
Ming‐Da Wang, Xuejun Xu, Ke‐Chun Wang, et al.
Cancer Science (2024) Vol. 115, Iss. 7, pp. 2159-2169
Open Access | Times Cited: 12
Ming‐Da Wang, Xuejun Xu, Ke‐Chun Wang, et al.
Cancer Science (2024) Vol. 115, Iss. 7, pp. 2159-2169
Open Access | Times Cited: 12
Hypoxia-activated cascade nanovaccine for synergistic chemoembolization-immune therapy of hepatocellular carcinoma
Qin Shi, Wen Zhang, Yongjie Zhou, et al.
Biomaterials (2024) Vol. 306, pp. 122480-122480
Closed Access | Times Cited: 11
Qin Shi, Wen Zhang, Yongjie Zhou, et al.
Biomaterials (2024) Vol. 306, pp. 122480-122480
Closed Access | Times Cited: 11
Evolving global etiology of hepatocellular carcinoma (HCC): Insights and trends for 2024.
Abraham Koshy
Journal of Clinical and Experimental Hepatology (2024) Vol. 15, Iss. 1, pp. 102406-102406
Closed Access | Times Cited: 9
Abraham Koshy
Journal of Clinical and Experimental Hepatology (2024) Vol. 15, Iss. 1, pp. 102406-102406
Closed Access | Times Cited: 9
Comparative Efficacy of Lenvatinib Plus Immunotherapy and Regorafenib Plus Immunotherapy After Lenvatinib Failure for Advanced Hepatocellular Carcinoma: A Retrospective Study
Zeyu Yu, Bin Leng, Ran You, et al.
Drugs - Real World Outcomes (2025)
Open Access | Times Cited: 1
Zeyu Yu, Bin Leng, Ran You, et al.
Drugs - Real World Outcomes (2025)
Open Access | Times Cited: 1
Unveiling the Intratumor Microbiome in Liver Cancer: Current Insights and Prospective Applications
Xindi Ke, Shangze Jiang, Qiaoxin Wei, et al.
Clinical and Molecular Hepatology (2025)
Open Access | Times Cited: 1
Xindi Ke, Shangze Jiang, Qiaoxin Wei, et al.
Clinical and Molecular Hepatology (2025)
Open Access | Times Cited: 1
Big lessons from the little Akkermansia muciniphila in hepatocellular carcinoma
Yanguang Yang, Xinli Shi
Frontiers in Immunology (2025) Vol. 16
Open Access | Times Cited: 1
Yanguang Yang, Xinli Shi
Frontiers in Immunology (2025) Vol. 16
Open Access | Times Cited: 1
Hepatocellular Carcinoma Screening: From Current Standard of Care to Future Directions
Michael Mohnasky, Sandra Gad, Andrew M. Moon, et al.
Journal of the American College of Radiology (2025) Vol. 22, Iss. 3, pp. 260-268
Closed Access | Times Cited: 1
Michael Mohnasky, Sandra Gad, Andrew M. Moon, et al.
Journal of the American College of Radiology (2025) Vol. 22, Iss. 3, pp. 260-268
Closed Access | Times Cited: 1
Dynamic prognostication and treatment planning for hepatocellular carcinoma: A machine learning-enhanced survival study using multi-centric data
Lujun Shen, Yiquan Jiang, Linbin Lu, et al.
The Innovation Medicine (2025), pp. 100125-100125
Closed Access | Times Cited: 1
Lujun Shen, Yiquan Jiang, Linbin Lu, et al.
The Innovation Medicine (2025), pp. 100125-100125
Closed Access | Times Cited: 1
Early detection and prognosis evaluation for hepatocellular carcinoma by circulating tumour DNA methylation: A multicentre cohort study
De‐Zhen Guo, Ao Huang, Ying‐Chao Wang, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 5
Open Access | Times Cited: 8
De‐Zhen Guo, Ao Huang, Ying‐Chao Wang, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 5
Open Access | Times Cited: 8
Efficacy and safety of hepatic arterial infusion chemotherapy combined with lenvatinib and PD-1 inhibitors for advanced hepatocellular carcinoma with macrovascular invasion
Yufeng Zhang, Haiyan Zhang, Haoqian Xu, et al.
World Journal of Surgical Oncology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 7
Yufeng Zhang, Haiyan Zhang, Haoqian Xu, et al.
World Journal of Surgical Oncology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 7
APASL clinical practice guidelines on systemic therapy for hepatocellular carcinoma-2024
George Lau, Shuntaro Obi, Jian Zhou, et al.
Hepatology International (2024) Vol. 18, Iss. 6, pp. 1661-1683
Open Access | Times Cited: 7
George Lau, Shuntaro Obi, Jian Zhou, et al.
Hepatology International (2024) Vol. 18, Iss. 6, pp. 1661-1683
Open Access | Times Cited: 7
Locoregional therapies for hepatocellular carcinoma: The current status and future perspectives
Jian‐Jian Chen, Zhi‐Cheng Jin, Bin‐Yan Zhong, et al.
United European Gastroenterology Journal (2024) Vol. 12, Iss. 2, pp. 226-239
Open Access | Times Cited: 6
Jian‐Jian Chen, Zhi‐Cheng Jin, Bin‐Yan Zhong, et al.
United European Gastroenterology Journal (2024) Vol. 12, Iss. 2, pp. 226-239
Open Access | Times Cited: 6
Adjuvant and neoadjuvant therapies for hepatocellular carcinoma
Arndt Vogel, Robert C. Grant, Tim Meyer, et al.
Hepatology (2023)
Closed Access | Times Cited: 14
Arndt Vogel, Robert C. Grant, Tim Meyer, et al.
Hepatology (2023)
Closed Access | Times Cited: 14
Real-world efficacy and safety of TACE-HAIC combined with TKIs and PD-1 inhibitors in initially unresectable hepatocellular carcinoma
Beichuan Pang, Bangyou Zuo, Liang Huang, et al.
International Immunopharmacology (2024) Vol. 137, pp. 112492-112492
Closed Access | Times Cited: 5
Beichuan Pang, Bangyou Zuo, Liang Huang, et al.
International Immunopharmacology (2024) Vol. 137, pp. 112492-112492
Closed Access | Times Cited: 5
The New Era of Systemic Treatment for Hepatocellular Carcinoma: From the First Line to the Optimal Sequence
Maria Cerreto, Ferdinando Cardone, Lucia Cerrito, et al.
Current Oncology (2023) Vol. 30, Iss. 10, pp. 8774-8792
Open Access | Times Cited: 12
Maria Cerreto, Ferdinando Cardone, Lucia Cerrito, et al.
Current Oncology (2023) Vol. 30, Iss. 10, pp. 8774-8792
Open Access | Times Cited: 12
Neoadjuvant drug-eluting bead transarterial chemoembolization and tislelizumab therapy for resectable or borderline resectable hepatocellular carcinoma: A propensity score matching analysis
Jianping Zhao, Jingjing Wang, Yuanxiang Lu, et al.
European Journal of Surgical Oncology (2023) Vol. 49, Iss. 12, pp. 107106-107106
Open Access | Times Cited: 12
Jianping Zhao, Jingjing Wang, Yuanxiang Lu, et al.
European Journal of Surgical Oncology (2023) Vol. 49, Iss. 12, pp. 107106-107106
Open Access | Times Cited: 12
HAIC plus lenvatinib and tislelizumab for advanced hepatocellular carcinoma with Vp4 portal vein invasion
Shuang‐Yan Tang, Feng Shi, Yi Xiao, et al.
Hepatology International (2025)
Closed Access
Shuang‐Yan Tang, Feng Shi, Yi Xiao, et al.
Hepatology International (2025)
Closed Access
Lenvatinib and tislelizumab versus atezolizumab and bevacizumab in combination with TAE-HAIC for unresectable hepatocellular carcinoma with high tumor burden: a multicenter retrospective cohort study
Hongjie Cai, Song Chen, Shuang‐Yan Tang, et al.
Cancer Immunology Immunotherapy (2025) Vol. 74, Iss. 3
Open Access
Hongjie Cai, Song Chen, Shuang‐Yan Tang, et al.
Cancer Immunology Immunotherapy (2025) Vol. 74, Iss. 3
Open Access
A real-world study of the efficacy of second-line treatment of unresectable hepatocellular carcinoma with esophagogastric varices after progression on first-line lenvatinib combined with PD-1 inhibitor
Saifeng Li, Qin Wen, Wen-wu Huang, et al.
World Journal of Surgical Oncology (2025) Vol. 23, Iss. 1
Open Access
Saifeng Li, Qin Wen, Wen-wu Huang, et al.
World Journal of Surgical Oncology (2025) Vol. 23, Iss. 1
Open Access
CD161, a promising prognostic biomarker in hepatocellular carcinoma, correlates with immune infiltration
Jinfeng Wang, Xiaoxiao Wang, Jianfei Shi, et al.
PeerJ (2025) Vol. 13, pp. e19055-e19055
Open Access
Jinfeng Wang, Xiaoxiao Wang, Jianfei Shi, et al.
PeerJ (2025) Vol. 13, pp. e19055-e19055
Open Access
Intra-arterial lidocaine improves long-term survival in patients with hepatocellular carcinoma undergoing transcatheter arterial chemoembolisation: a retrospective propensity score-matched study
Fang Yan, Wanyu Wang, Zhiwen Yang, et al.
British Journal of Anaesthesia (2025)
Open Access
Fang Yan, Wanyu Wang, Zhiwen Yang, et al.
British Journal of Anaesthesia (2025)
Open Access
Blood-based machine learning classifiers for early diagnosis of gastric cancer via multiple miRNAs
Fu‐Chao Ma, Guan-Lan Zhang, Bang‐Teng Chi, et al.
World Journal of Gastrointestinal Oncology (2025) Vol. 17, Iss. 4
Closed Access
Fu‐Chao Ma, Guan-Lan Zhang, Bang‐Teng Chi, et al.
World Journal of Gastrointestinal Oncology (2025) Vol. 17, Iss. 4
Closed Access
Next‐Generation Flexible Embolic Systems: Targeted Transarterial Chemoembolization Strategies for Hepatocellular Carcinoma
Han Wu, Shao-Dong Lv, Renjie Zhang, et al.
Advanced Materials (2025)
Closed Access
Han Wu, Shao-Dong Lv, Renjie Zhang, et al.
Advanced Materials (2025)
Closed Access
